Merck Tbk. vs Penta Valent Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Penta Valent Tbk. trades at Rp310 (market cap 547.34B, 520.2K 24h volume). The key difference: Merck Tbk. is far larger — about 3.1× Penta Valent Tbk.'s market cap, and Penta Valent Tbk. is more actively traded (520.2K versus 37.6K). Which is the better fit depends on your goals.
| MERK | PEVE | |
|---|---|---|
Market Cap | 1.7T | 547.34B |
Volume | 37.6K | 520.2K |
Lot | 376 | 5.2K |
Turnover | 144.47M | 161.08M |
Average Price | 3,842.23 | 309.65 |
Value | 144.47M | 161.08M |
Indicative Equilibrium Price | 3,840 | — |
Indicative Equilibrium Volume | 7 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Penta Valent Tbk (the Company) was established in 1968 in Jakarta, Indonesia under the name of CV Penta Valent, hereinafter, based on Notarial Deed No. 48 of Bebasa Daeng Lalo, S.H., dated August 16, 1972. The Company started its commercial operations in 1968. PT Tancorp Global Sentosa, a company incorporated in Indonesia, is the ultimate parent entity of the Company.
Read more on PEVE →